Search
for

    Learn

    4 / 4 results

    Research

    5 / 1000+ results

    Community Join

    5 / 106 results

      community Has anybody experimented with home-remedy sprays to promote hair growth?

      in Treatment  4 upvotes 3 months ago
      A user is considering using homemade hair sprays with ingredients like fenugreek seeds, rosemary, and lavender to promote hair growth, alongside topical minoxidil. Other users suggest that while these sprays may improve hair health, they are not as effective as minoxidil and finasteride for regrowing hair, and recommend using proven treatments like finasteride for better results.

      community Bryan Johnson just dropped his anti hair loss formula

      in Treatment  340 upvotes 2 years ago
      Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.

      community Melatonin a possible tool to help fight AGA hair loss.

      in Research/Science  50 upvotes 4 years ago
      Topical melatonin may help reduce hair loss and increase hair thickness in people with androgenetic alopecia (AGA), with some studies showing positive results. It can be mixed with minoxidil for application, and its effectiveness might be enhanced when used with micro-needling, but results may vary among individuals.

      community ~1 year using rosemary shampoo (trigger warning)

      in Progress Pictures  158 upvotes 1 year ago
      A user reported hair thickening and a stronger crown after using rosemary shampoo for about a year, with progress pictures as evidence. Some commenters discussed the effectiveness of natural treatments versus pharmaceutical options like Minoxidil and Finasteride.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 3 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.